Fusion Genomics Corporation

Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination with our FUSIONCloud data analysis platform, enable rapid identification of the genetic signatures of human pathogens and cancers accurately and economically. FUSION’s ONETest platform is currently being tested at various key opinion leaders in Canada and the European Union. Our mission is to provide global and local healthcare providers the tools they need to perform both population surveillance and individual diagnosis of pathogens to prevent unnecessary deaths and halt the growing problem of disease drug resistance.